摘要
肝硬化是我国临床上的常见病，肝硬化失代偿期常出现明显腹水，预后不良，但恰当治疗不仅可以消退腹水，而且尚可防止其它合并症。本文报道我们观察的肝硬化门脉高压合并腹水患者２７０例，经试用新型免疫调节剂——抗乙肝胎盘肽，改善肝内炎症，同时合理使用利尿剂，补充蛋白等综合治疗，多数患者获得较好临床效果。
Liver cirrhosis is a common disease in our country and the most common clinicalmanifestation of decompensated liver cirrhosis is portal but also the other complications might be pre-vented by proper treatment. The majority cases of portal hypertension with ascites could get better re-sults from multiple treatment with mainly antihepatitis B placenta polypeptide for reliving inflammatoryreaction in the liver,and proper diuretics and blood plasma for diuresis.
出处
《泰山医学院学报》
1995年第3期223-226,共4页
Journal of Taishan Medical College
关键词
失代偿期肝硬化
治疗
抗乙肝胎盘肽
肝硬变
decompenseted liver cirrhosis
multiple treatment
antihepatitis B placentapolypeptide.
